Trial Profile
A Multi-Database, Cohort Study Comparing the Cardiovascular Safety of Tocilizumab Versus Abatacept in Patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2017
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Abatacept
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 15 Dec 2017 New trial record
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.